Torrent Pharma to acquire Encore's derma business

15 Apr 2015 Evaluate

Torrent Pharmaceuticals, is in talks to acquire the dermatology business of Mumbai-headquartered Encore group. The acquisition value of the dermatology business is around Rs 350 crore.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments

Torrent Pharma Share Price

4284.35 -103.65 (-2.36%)
16-Mar-2026 12:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.50
Dr. Reddys Lab 1271.05
Cipla 1300.60
Zydus Lifesciences 886.10
Lupin 2281.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×